Is BrightSpring Health Services (BTSG) overvalued or fairly valued?

MarketChacha shows BrightSpring Health Services's valuation in context — a trailing P/E of about 58.2, a forward P/E of about 32.7, a price-to-book of about 7.2 — alongside its revenue and profit growth and whether reported profit converts into operating cash, so you can judge value for yourself. MarketChacha does not issue ratings, price targets, or buy/sell advice.

Does BrightSpring Health Services's reported profit turn into cash?

Over 3 years, operating cash flow fully covered reported profit — earnings are backed by real cash. MarketChacha computes this cash-conversion check (40.26×) from reported figures — education, not a rating.

What is BrightSpring Health Services's revenue?

BrightSpring Health Services reported revenue of $12.9B for FY2025, with net profit of $190.7M, per official filings.

What is the share price of BrightSpring Health Services (BTSG)?

BrightSpring Health Services last traded at $69.87 (-3.7% on the day), as of 7/22/2026 — a delayed quote shown for education, not investment advice.

BrightSpring Health Services

BTSG · NYSE · Healthcare · United States

$69.87-3.7%

Delayed · as reported by Yahoo Finance · as of Jul 22, 2026, 7:32 PM

Snapshot

TickerBTSG

ExchangeNYSE

SectorHealthcare

IndustryHealth Information Services

CountryUnited States

Employees23,500

HeadquartersLouisville, United States

Market cap$13.7B

P/E (TTM)58.2

P/B7.2

Volume1.52M

Websitewww.brightspringhealth.com

Filings tracked6

About BrightSpring Health Services

BrightSpring Health Services, Inc. operates as a home and community-based healthcare services platform in the United States. The company operates through two segments, Pharmacy Solutions and Provider Services. Its platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations. It also offers infused, injectable, and oral medication services; and patient-centric, highly skilled, and compassionate clinical home health care, as well as rehabilitation services, including physical, speech and occupational therapy and applied behavioral analysis. The company was formerly known as Phoenix Parent Holdings Inc. and changed its name to BrightSpring Health Services, Inc. in May 2021. BrightSpring Health Services, Inc. was founded in 1974 and is headquartered in Louisville, Kentucky.

Profile as reported by Yahoo Finance.

Who owns it

Insiders3.2%
Institutions96.8%
Public & other0.0%

491 institutional holders

As reported by Yahoo Finance.

Top holders

Kohlberg Kravis Roberts & Co. L.P.21.20%
FMR, LLC10.63%
Blackrock Inc.9.94%
Invesco Ltd.5.82%
Price (T.Rowe) Associates Inc5.41%
Vanguard Portfolio Management LLC4.07%
T. Rowe Price Investment Management, Inc.3.87%
Vanguard Capital Management LLC3.19%

Largest institutional holders, as reported by Yahoo Finance (as of 3/31/2026).

Forensic scorecard

No major accounting red flags in the fundamentals we have — profit is backed by cash and returns look healthy.

Cash conversion40.26×

Over 3 years, operating cash flow fully covered reported profit — earnings are backed by real cash.

Net margin trend-2.0% → 1.5%

Margin has expanded by about 3.5 points — the business is getting more profitable.

Computed by MarketChacha from reported figures (SEC XBRL). Education, not a rating or recommendation.

What's expected next

Next quarter

Rev $3.8B · EPS 0.44

Est. earnings growth +46.4%

Next fiscal year

Rev $17.1B · EPS 2.14

Est. earnings growth +25.8%

Analyst consensus estimates — not the company's own guidance. As reported by Yahoo Finance.

$19.0152-wk range$73.40

Delayed · as reported by Yahoo Finance

New to these terms?

P/E ROE ROCE Margins Market cap

Browse the Learn hub →

Financials at a glance

Source: SEC XBRL

Annual

Quarterly · last 8

Market cap

$13.7B

Day change

-3.7%

P/E (TTM)

58.2

Fwd P/E

32.7

P/B

7.2

Beta

1.79

Revenue (FY2025)

$12.9B

Net margin

1.5%

ROE

10.2%

Revenue CAGR (2y)

+29.6%

EPS (FY2025)

0.87

Net profit (FY2025)

$190.7M

Market figures: Delayed · as reported by Yahoo Finance. Financials as reported in company filings.

Ask MarketChacha about BTSG

Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.

Financials

Yearly

Period	Revenue	Net profit	EPS	Net margin	ROE
FY2025	$12.9B	$190.7M	0.87	1.5%	10.2%
FY2024	$10.1B	$-18.1M	-0.09	-0.2%	-1.1%
FY2023	$7.7B	$-154.6M	-1.31	-2.0%	-26.4%

Quarterly

Period	Revenue	Net profit	EPS	Net margin
2026Q1	$3.6B	$148.8M	0.67	4.1%
2025Q3	$3.3B	$55.8M	0.26	1.7%
2025Q2	$3.1B	$28.2M	0.13	0.9%
2025Q1	$2.9B	$29.5M	0.14	1.0%
2024Q3	$2.6B	$-8.2M	-0.04	-0.3%
2024Q2	$2.4B	$19.9M	0.10	0.8%
2024Q1	$2.3B	$-45.8M	-0.26	-2.0%
2023Q3	$2.3B	$-130.7M	-1.11	-5.8%
2023Q2	$2.2B	$4.0M	0.03	0.2%
2023Q1	$2.0B	$-21.4M	-0.18	-1.1%

Figures as reported, in reporting currency. Source: SEC XBRL.

Filings & announcements

2026

8-K — Executive/director change, Reg FD disclosure, Exhibits
SEC6/12/2026material
8-K — Material agreement, Exhibits
SEC6/5/2026material
8-K — Shareholder vote results
SEC5/21/2026material
8-K — Results of operations, Exhibits
SEC5/1/2026material
10-Q filing
SEC5/1/2026
8-K — Completion of acquisition/disposition, Executive/director change, Reg FD disclosure, Exhibits
SEC3/31/2026material

In the news

Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed · as reported by yahoo finance) are delayed and shown for reference only. Verify with the linked sources before acting.